Edwards Lifesciences Corporation

Edwards Lifesciences Corporation

EW
Edwards Lifesciences CorporationUS flagNew York Stock Exchange
76.18
USD
+0.05
(+0.06%)
2.42EPS
31.48P/E
44.69BMarket Cap
Jul 24Next Earn
Capital Structure

in mil. unless spec.
Working Capital

in mil. unless spec.
Growth Rates

in mil. unless spec.
Quarterly Revenue

in mil. unless spec.
Quarterly Earnings Per Share

in mil. unless spec.
Quarterly Dividends Per Share

in mil. unless spec.

Company Description

CEO
Bernard J. Zovighian
Full Time Employees
15,800
Sector
Healthcare
Industry
Medical - Devices
Address
One Edwards Way Irvine CA United States of America 92614
IPO Date
Mar 27, 2000
Similar Companies
Business
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Company News

  • Smart Money Going in Senior Health: Key Stocks in Elderly Care

  • East West Petroleum Provides Corporate Update

  • East West Petroleum Provides Corporate Update

  • Edwards Lifesciences: With A Heart Beating Strong And Steady

  • Edwards' New Late-Breaking Data on Severe AS Expected to Boost Stock

  • Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes

  • Trade Tracker: Bill Baruch buys Edwards Lifesciences

  • Should Edwards Lifesciences Stock Remain in Your Portfolio Now?

  • Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference

  • Edwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook Brightens

  • EW Q1 Earnings & Revenues Beat, Stock Climbs, '25 Sales View Raised

  • Edwards Lifesciences Corporation (EW) Q1 2025 Earnings Call Transcript

  • Edwards Lifesciences (EW) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

  • Edwards Lifesciences raises 2025 sales forecast after robust quarter

  • Edwards Lifesciences Delivers In-Line Sales, Narrow Profit Beat

  • Edwards Lifesciences Reports First Quarter Results

  • Unlocking Q1 Potential of Edwards Lifesciences (EW): Exploring Wall Street Estimates for Key Metrics

  • Eight-Year Data Confirm Long-Term Durability of Edwards' RESILIA Tissue

  • Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings

  • Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025